Clinical Trials

NCT00892203 | COMPLETED | PHASE2

75 participants

Efficacy and Safety of BGG492 in the Treatment of Migraine

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2009-04-30

Completion:

2010-08-31

Conditions

• Migraine

Interventions

• DRUG

No Results Yet

NCT00861380 | COMPLETED | PHASE3

41188 participants

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2009-05-04

Completion:

2012-01-31

Conditions

• Infections, Streptococcal
• Streptococcus Pneumoniae

Interventions

• BIOLOGICAL

Results Available

NCT00844740 | WITHDRAWN | NA

0 participants

Calcimimetics in Hypophosphatemic Rickets

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2009-03-01

Completion:

2012-03-01

Conditions

• Familial Hypophosphatemic Rickets

Interventions

• DRUG

No Results Yet

NCT00839254 | COMPLETED | PHASE3

6181 participants

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2009-02-18

Completion:

2012-01-31

Conditions

• Infections, Streptococcal
• Streptococcus Pneumoniae

Interventions

• BIOLOGICAL

Results Available

NCT00830531 | COMPLETED | PHASE1

43 participants

Pilot Study of Bumetanide for Newborn Seizures

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2010-01-31

Completion:

2019-01-31

Conditions

• Seizures

Interventions

• DRUG

No Results Yet

NCT00821977 | COMPLETED | PHASE2/PHASE3

338 participants

Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-11-30

Completion:

2010-10-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00818571 | COMPLETED | PHASE1/PHASE2

96 participants

Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-12-31

Completion:

2009-05-31

Conditions

• Renal Impairment
• Diabetes

Interventions

• DRUG

No Results Yet

NCT00795418 | COMPLETED | PHASE2

31 participants

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-10-31

Completion:

2010-11-30

Conditions

• Alzheimer's Disease

Interventions

• BIOLOGICAL

No Results Yet

NCT00788762 | UNKNOWN

840 participants

Myocilin Variations and Familial Glaucoma in Taxiarchis

Study Type:

OBSERVATIONAL

Last Updated:

2020-12-17

Start Date:

2007-08-31

Completion:

2022-12-31

Conditions

• Glaucoma

No Results Yet

NCT00777218 | WITHDRAWN | NA

0 participants

Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2007-08-31

Completion:

2010-12-31

Conditions

• Migraine

Interventions

• DRUG

No Results Yet

NCT00770081 | COMPLETED | PHASE3

75 participants

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-09-30

Completion:

2011-04-30

Conditions

• Diabetes Mellitus, Type 2
• Renal Insufficiency

Interventions

• DRUG

No Results Yet

NCT00765830 | COMPLETED | PHASE3

349 participants

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-09-30

Completion:

2011-04-30

Conditions

• Diabetes Mellitus, Type 2
• Renal Insufficiency

Interventions

• DRUG

No Results Yet

NCT00757835 | COMPLETED | PHASE4

40 participants

24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-05-31

Completion:

2009-03-31

Conditions

• Glaucoma

Interventions

• DRUG

No Results Yet

NCT00708292 | COMPLETED | PHASE1/PHASE2

29 participants

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-07-31

Completion:

2011-01-31

Conditions

• Relapsed or Refractory Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT00670592 | COMPLETED | PHASE1/PHASE2

111 participants

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-03-31

Completion:

2013-02-28

Conditions

• Non-Hodgkin's Lymphoma
• Hodgkin's Lymphoma

Interventions

• DRUG

No Results Yet

NCT00646542 | COMPLETED | PHASE3

525 participants

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2005-03-31

Completion:

2010-10-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00633997 | TERMINATED | PHASE1/PHASE2

22 participants

Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-02-29

Completion:

2008-12-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00616811 | COMPLETED | PHASE3

148 participants

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2008-01-31

Completion:

2010-10-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00615784 | TERMINATED | PHASE2

24 participants

Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2010-05-25

Completion:

2013-10-01

Conditions

• Acute Myeloid Leukemia

Interventions

• DRUG

Results Available

NCT00600275 | COMPLETED | PHASE1/PHASE2

57 participants

A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2007-12-31

Completion:

2010-03-31

Conditions

• Solid Tumors
• Breast Cancer
• Cowden Syndrome

Interventions

• DRUG

No Results Yet

NCT00597246 | COMPLETED | NA

30 participants

Imaging Brain Tumors With FACBC and Methionine

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2003-05-13

Completion:

2019-11-27

Conditions

• Brain Cancer
• CNS Cancer

Interventions

• DRUG
• OTHER

Results Available

NCT00555789 | TERMINATED | PHASE2

137 participants

24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2007-10-31

Completion:

2008-03-31

Conditions

• Kidney Transplantation

Interventions

• DRUG

No Results Yet

NCT00533910 | COMPLETED | NA

42 participants

Rifaximin in Minimal Hepatic Encephalopathy

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2007-10-31

Completion:

2010-04-30

Conditions

• Hepatic Encephalopathy

Interventions

• DRUG

Results Available

NCT00526045 | COMPLETED | PHASE1/PHASE2

117 participants

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2007-07-31

Completion:

2012-04-30

Conditions

• Breast Cancer
• Hematologic Neoplasms

Interventions

• DRUG

No Results Yet

NCT00411528 | COMPLETED | PHASE2

185 participants

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2006-09-30

Completion:

2012-09-30

Conditions

• Metastatic Hormone Refractory Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT00403416 | COMPLETED | PHASE1/PHASE2

215 participants

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2006-10-31

Completion:

2008-05-31

Conditions

• Kidney Transplantation

Interventions

• DRUG

No Results Yet

NCT00396357 | COMPLETED | PHASE3

914 participants

Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2006-10-31

Completion:

2008-06-30

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00387244 | TERMINATED | NA

7 participants

Efficacy of the Spinal Cord Stimulation System as Salvage Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2006-08-31

Completion:

2008-04-30

Conditions

• Pain
• Intractable Pain
• Chronic Pain

Interventions

• DEVICE

Results Available

NCT00386724 | TERMINATED | NA

8 participants

Effectiveness of Precision Spinal Cord Stimulation With Artisan Paddle Electrode

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2006-10-31

Completion:

2008-08-31

Conditions

• Back Pain
• Chronic Pain
• Pain in Leg, Unspecified

Interventions

• DEVICE

Results Available

NCT00383578 | COMPLETED | PHASE3

335 participants

Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2006-09-30

Completion:

2008-05-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00370695 | TERMINATED | NA

15 participants

Spinal Cord Stimulation for Chronic and Intractable Back Pain

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2006-02-28

Completion:

2008-07-31

Conditions

• Back Pain

Interventions

• DEVICE

Results Available

NCT00285363 | WITHDRAWN

0 participants

Quality of Life Among Children and Adolescents With Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2020-12-17

Start Date:

2005-03-31

Completion:

2013-02-28

Conditions

• Cancer

No Results Yet

NCT00262990 | COMPLETED | PHASE3

829 participants

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2005-11-30

Completion:

2010-02-28

Conditions

• Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Neoplasms

Interventions

• DRUG

No Results Yet

NCT00260156 | COMPLETED | PHASE3

59 participants

A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2005-11-30

Completion:

2008-12-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00106340 | COMPLETED | PHASE3

3118 participants

Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2005-03-31

Completion:

2008-05-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00102466 | COMPLETED | PHASE3

1007 participants

Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2005-01-31

Completion:

2009-01-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00099853 | COMPLETED | PHASE3

362 participants

Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

2004-05-31

Completion:

2008-01-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT00003526 | TERMINATED | PHASE2

8 participants

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-17

Start Date:

1996-03-18

Completion:

2005-02-02

Conditions

• Unknown Primary Carcinoma

Interventions

• DRUG

Results Available

NCT04669470 | UNKNOWN | NA

100 participants

Bariatric Endoscopy and NAFLD

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-16

Start Date:

2020-10-01

Completion:

2022-12-31

Conditions

• Obesity
• NAFLD
• Liver Steatosis
• Liver Fibrosis

Interventions

• PROCEDURE

No Results Yet

NCT04669431 | COMPLETED | NA

58 participants

Xbox Kinect Training on Upper Limb Motor Function in Stroke Patients

Study Type:

INTERVENTIONAL

Last Updated:

2020-12-16

Start Date:

2018-06-18

Completion:

2019-02-01

Conditions

• Stroke

Interventions

• OTHER

No Results Yet